Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1478-6362

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout ; volume:22 ; number:1 ; day:12 ; month:3 ; year:2020 ; pages:1-10 ; date:12.2020
Arthritis Research & Therapy ; 22, Heft 1 (12.3.2020), 1-10, 12.2020

Creator: Wrigley, Rebekah
Phipps-Green, Amanda J.
Topless, Ruth K.
Major, Tanya J.
Cadzow, Murray
Riches, Philip
Tausche, Anne-Kathrin
Janssen, Matthijs
Joosten, Leo A. B.
Jansen, Tim L.
So, Alexander
Harré Hindmarsh, Jennie
Stamp, Lisa K.
Dalbeth, Nicola
Merriman, Tony

Contributor: SpringerLink (Online service)

DOI: 10.1186/s13075-020-2136-z

URN: urn:nbn:de:101:1-2020060405580689554971

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:52 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Wrigley, Rebekah
Phipps-Green, Amanda J.
Topless, Ruth K.
Major, Tanya J.
Cadzow, Murray
Riches, Philip
Tausche, Anne-Kathrin
Janssen, Matthijs
Joosten, Leo A. B.
Jansen, Tim L.
So, Alexander
Harré Hindmarsh, Jennie
Stamp, Lisa K.
Dalbeth, Nicola
Merriman, Tony
SpringerLink (Online service)

Other Objects (12)

Familial early-onset hyperuricemia and gout associated with a newly identified dysfunctional variant in urate transporter ABCG2

Epistatic interaction between PKD2 and ABCG2 influences the pathogenesis of hyperuricemia and gout

Genetic polymorphisms and decreased protein expression of ABCG2 urate transporters are associated with susceptibility to gout, disease severity and renal-overload hyperuricemia

Susceptibility genes of hyperuricemia and gout

ABCG2 contributes to the development of gout and hyperuricemia in a genome-wide association study

The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients

Influence of the ABCG2 gout risk 141 K allele on urate metabolism during a fructose challenge

Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment

Circulating microRNA alternations in primary hyperuricemia and gout

Variation in serum urate levels in the absence of gout and urate lowering therapy

Fluctuation and change of serum urate levels and flares in gout: results from the NOR-Gout study

The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial

Familial early-onset hyperuricemia and gout associated with a newly identified dysfunctional variant in urate transporter ABCG2

Epistatic interaction between PKD2 and ABCG2 influences the pathogenesis of hyperuricemia and gout

Genetic polymorphisms and decreased protein expression of ABCG2 urate transporters are associated with susceptibility to gout, disease severity and renal-overload hyperuricemia

Susceptibility genes of hyperuricemia and gout

ABCG2 contributes to the development of gout and hyperuricemia in a genome-wide association study

The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients

Influence of the ABCG2 gout risk 141 K allele on urate metabolism during a fructose challenge

Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment

Circulating microRNA alternations in primary hyperuricemia and gout

Variation in serum urate levels in the absence of gout and urate lowering therapy

Fluctuation and change of serum urate levels and flares in gout: results from the NOR-Gout study

The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial

Familial early-onset hyperuricemia and gout associated with a newly identified dysfunctional variant in urate transporter ABCG2

Epistatic interaction between PKD2 and ABCG2 influences the pathogenesis of hyperuricemia and gout

Genetic polymorphisms and decreased protein expression of ABCG2 urate transporters are associated with susceptibility to gout, disease severity and renal-overload hyperuricemia

Susceptibility genes of hyperuricemia and gout

ABCG2 contributes to the development of gout and hyperuricemia in a genome-wide association study

The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients

Influence of the ABCG2 gout risk 141 K allele on urate metabolism during a fructose challenge

Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment

Circulating microRNA alternations in primary hyperuricemia and gout

Variation in serum urate levels in the absence of gout and urate lowering therapy

Fluctuation and change of serum urate levels and flares in gout: results from the NOR-Gout study

The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Familial early-onset hyperuricemia and gout associated with a newly identified dysfunctional variant in urate transporter ABCG2

Epistatic interaction between PKD2 and ABCG2 influences the pathogenesis of hyperuricemia and gout

Genetic polymorphisms and decreased protein expression of ABCG2 urate transporters are associated with susceptibility to gout, disease severity and renal-overload hyperuricemia

Susceptibility genes of hyperuricemia and gout

ABCG2 contributes to the development of gout and hyperuricemia in a genome-wide association study

The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients

Influence of the ABCG2 gout risk 141 K allele on urate metabolism during a fructose challenge

Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment

Circulating microRNA alternations in primary hyperuricemia and gout

Variation in serum urate levels in the absence of gout and urate lowering therapy

Fluctuation and change of serum urate levels and flares in gout: results from the NOR-Gout study

The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial

Familial early-onset hyperuricemia and gout associated with a newly identified dysfunctional variant in urate transporter ABCG2

Epistatic interaction between PKD2 and ABCG2 influences the pathogenesis of hyperuricemia and gout

Genetic polymorphisms and decreased protein expression of ABCG2 urate transporters are associated with susceptibility to gout, disease severity and renal-overload hyperuricemia

Susceptibility genes of hyperuricemia and gout

ABCG2 contributes to the development of gout and hyperuricemia in a genome-wide association study

The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients

Influence of the ABCG2 gout risk 141 K allele on urate metabolism during a fructose challenge

Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment

Circulating microRNA alternations in primary hyperuricemia and gout

Variation in serum urate levels in the absence of gout and urate lowering therapy

Fluctuation and change of serum urate levels and flares in gout: results from the NOR-Gout study

The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial

Familial early-onset hyperuricemia and gout associated with a newly identified dysfunctional variant in urate transporter ABCG2

Epistatic interaction between PKD2 and ABCG2 influences the pathogenesis of hyperuricemia and gout

Genetic polymorphisms and decreased protein expression of ABCG2 urate transporters are associated with susceptibility to gout, disease severity and renal-overload hyperuricemia

Susceptibility genes of hyperuricemia and gout

ABCG2 contributes to the development of gout and hyperuricemia in a genome-wide association study

The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients

Influence of the ABCG2 gout risk 141 K allele on urate metabolism during a fructose challenge

Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment

Circulating microRNA alternations in primary hyperuricemia and gout

Variation in serum urate levels in the absence of gout and urate lowering therapy

Fluctuation and change of serum urate levels and flares in gout: results from the NOR-Gout study

The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial

Related objects

Reset password